Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.

Eriksson BI, Dahl OE, Huo MH, Kurth AA, Hantel S, Hermansson K, Schnee JM, Friedman RJ; RE-NOVATE II Study Group..

Thromb Haemost. 2011 Apr;105(4):721-9. doi: 10.1160/TH10-10-0679. Epub 2011 Jan 12.

PMID:
21225098
2.

Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.

Lassen MR, Gallus A, Raskob GE, Pineo G, Chen D, Ramirez LM; ADVANCE-3 Investigators..

N Engl J Med. 2010 Dec 23;363(26):2487-98. doi: 10.1056/NEJMoa1006885.

3.

Resolving controversies in hip fracture care: the need for large collaborative trials in hip fractures.

Bhandari M, Sprague S, Schemitsch EH; International Hip Fracture Research Collaborative..

J Orthop Trauma. 2009 Jul;23(6):479-84. doi: 10.1097/BOT.0b013e3181a772e3. Review.

4.

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.

Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W; RECORD1 Study Group..

N Engl J Med. 2008 Jun 26;358(26):2765-75. doi: 10.1056/NEJMoa0800374.

5.
6.

Pulmonary surfactant films affected by solvent vapors.

Enhorning G, Pototschnik R, Possmayer F, Burgoyne R.

Anesth Analg. 1986 Dec;65(12):1275-80.

PMID:
3777456
7.

Analysis of HLA B27 in ankylosing spondylitis with human alloreactive cytolytic T lymphocyte clones: failure to detect disease-related T cell epitopes.

Czitrom AA, Pototschnik R, Edwards S, Gladman DD, Falk JA.

Exp Clin Immunogenet. 1986;3(3):129-37.

PMID:
2484102
8.

Lung expansion and survival in rabbit neonates treated with surfactant extract.

Metcalfe IL, Pototschnik R, Burgoyne R, Enhorning G.

J Appl Physiol Respir Environ Exerc Physiol. 1982 Oct;53(4):838-43.

PMID:
6897547

Supplemental Content

Loading ...
Support Center